Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
On Wednesday, IMMvention Therapeutix, Inc. announced a strategic collaboration and license agreement with Novo Nordisk A/S NVO to co-develop oral therapies for...
One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs that's proven to be both efficacio...
Blockbuster weight loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) can reduce the risk of Alzheimer’s, a major new study has revealed. Invest with Confi...
Analyst ratings
71%
of 31 ratingsMore NVO News
...
Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to crown any winners in the race for th...
It hasn't been a great period for investors in Novo Nordisk (NVO -5.27%) despite its ongoing status as one of the pharmaceutical industry's apex competitors in...
A shake-up may be brewing in the market for GLP-1 diet drugs Friday, and it's making itself felt all across the field of companies selling (or hoping to sell) s...
After Novo Nordisk (NVO) reported results from its Phase 3b STEP UP trial, which showed that adults with obesity achieved a 20.7% weight loss over 72 weeks with...
The 15 drugs include GLP-1s like Ozempic and Wegovy and were used by over 5 million Americans. Ozempic is among the new slate of medications that will be subje...
On Friday, Novo Nordisk A/S NVO released headline results from the STEP UP Phase 3b trial in the global STEP program. Semaglutide 2.4 mg is marketed under the...
